PX4 Stock Chart & Stats
€204.00
€4.00(1.79%)
At close: 4:00 PM EDT
€204.00
€4.00(1.79%)
Day’s Range― - ―
52-Week Range€114.00 - €262.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€5.59B
Enterprise Value€7.50K
Total Cash (Recent Filing)€314.05M
Total Debt (Recent Filing)€299.35M
Price to Earnings (P/E)35.5
Beta0.27
Next Earnings
Oct 28, 2026EPS Estimate
2.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.92
Shares Outstanding26,652,100
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.40
Price to Book (P/B)2.66
Price to Sales (P/S)0.96
P/FCF Ratio25.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€271.24Price Target Upside32.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)7.46
Revenue Forecast (FY)€4.22B
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Program PipelinePlexus is adding substantial future program revenue while expanding its qualified opportunity funnel. The combination of strong current growth, new customer programs, and end-market wins supports multi-quarter visibility and reduces reliance on a single product cycle.
Improving Profitability And Capital EfficiencyImproved operating performance and returns indicate that Plexus is converting growth into better economics. Sustained margin expansion and ROIC above the cost of capital can strengthen reinvestment capacity and support durable value creation across programs.
Conservative Leverage And LiquidityLow leverage limits balance-sheet risk and preserves flexibility as Plexus funds capacity, working capital, or strategic investments. The expanded liquidity position provides additional resilience against supply-chain needs and supports growth without excessive financial strain.
Bears Say
Weak And Volatile Recent Cash ConversionPositive earnings are not currently translating consistently into cash. Working-capital requirements and investment swings can absorb operating cash, limiting funding available for expansion, buybacks, and debt reduction while increasing execution sensitivity.
Modest Margins Increase Operating SensitivityEMS economics remain relatively low-margin, so small changes in customer mix, pricing, component costs, or factory utilization can materially affect earnings. This limits the cushion available if demand weakens or operational costs rise.
Uneven End-Market Growth OutlookPlexus benefits from aerospace, defense, industrial, and healthcare exposure, but growth is not uniform across those markets. Healthcare normalization and unresolved commercial aerospace recovery could temper portfolio-wide growth and create uneven capacity utilization.
Plexus News
PX4 FAQ
What was Plexus’s price range in the past 12 months?
Plexus lowest stock price was €114.00 and its highest was €262.00 in the past 12 months.
What is Plexus’s market cap?
Plexus’s market cap is €5.59B.
When is Plexus’s upcoming earnings report date?
Plexus’s upcoming earnings report date is Oct 28, 2026 which is in 61 days.
How were Plexus’s earnings last quarter?
Plexus released its earnings results on Jul 29, 2026. The company reported €2.015 earnings per share for the quarter, beating the consensus estimate of €1.852 by €0.163.
Is Plexus overvalued?
According to Wall Street analysts Plexus’s price is currently Undervalued.
Does Plexus pay dividends?
Plexus does not currently pay dividends.
What is Plexus’s EPS estimate?
Plexus’s EPS estimate is 2.22.
How many shares outstanding does Plexus have?
Plexus has 26,652,100 shares outstanding.
What happened to Plexus’s price movement after its last earnings report?
Plexus reported an EPS of €2.015 in its last earnings report, beating expectations of €1.852. Following the earnings report the stock price went down -4.587%.
Which hedge fund is a major shareholder of Plexus?
Currently, no hedge funds are holding shares in DE:PX4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Plexus Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€271.24 (32.96% Upside)
€271.24 (32.96% Upside)
Blogger Sentiment
Neutral
DE:PX4 Sentiment 60%
Sector Average 59%
Sector Average 59%
Insider Transactions
Sold Shares
Worth $703.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
115.10%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
17.00%
Trailing 12-Months
Company Description
Plexus
Operating globally across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions, Plexus Corp. and its subsidiaries specialize in delivering advanced electronic manufacturing solutions. The company provides a comprehensive range of services, including design and development, efficient supply chain management, support for new product introductions, and core manufacturing capabilities, alongside essential aftermarket services. These offerings are tailored for businesses in key market segments such as healthcare/life sciences, industrial/commercial, aerospace/defense, and communications. Established in 1979, Plexus Corp. maintains its corporate headquarters in Neenah, Wisconsin.
PX4 Company Deck
PX4 Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive overall: Plexus reported record quarterly revenue (+28% YoY), delivered improved operating margin and an EPS beat, announced substantial new program wins and a record $4.5 billion funnel, and showed marked working capital improvements (62-day cash cycle, 14.9% ROIC). Management provided bullish guidance for fiscal Q4 and fiscal 2026 (revenue growth >20%) and signaled potential for continued margin expansion and strong free cash flow in fiscal 2027. Key near-term concerns include supply-chain-driven inventory preplacement that pressures working capital (leading to a Q4 free cash flow breakeven/slight usage), rising interest/non-operating expense, and expected moderation in Healthcare growth and incomplete recovery in commercial aerospace. Overall, the positive operational momentum, sizable wins funnel and improved capital efficiency outweigh the manageable near-term headwinds.View all DE:PX4 earnings summariesPX4 Stock 12 Month Forecast
Average Price Target
€271.24
▲(32.96% Upside)